| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
56 |
38 |
$4K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
99 |
94 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
56 |
54 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
67 |
66 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
41 |
39 |
$1K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
35 |
35 |
$1K |
| 87428 |
|
20 |
20 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
42 |
40 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
31 |
31 |
$970.30 |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
30 |
29 |
$901.60 |
| 99349 |
|
13 |
12 |
$475.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
30 |
29 |
$471.00 |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
27 |
16 |
$349.23 |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
39 |
31 |
$213.34 |
| 87070 |
|
17 |
17 |
$105.40 |